Millions of bottles of over-the-counter eye drops used to treat redness, dryness, and eye strain have been recalled due to concerns about their sterility, according to a Food and Drug Administration enforcement report.
Recall Details
The recall, initiated voluntarily by the Vietnam-based company Rohto-Mentholatum, affects 11,960,623 cartons of Rohto Cooling Eye Drops distributed nationwide. The FDA has designated it a Class II recall, meaning using the products may cause temporary or reversible health effects, but are not likely to result in serious consequences.
The recall affects select lots of eight Rohto Cooling Eye Drops varieties sold in single and twin-packs with expiration dates ranging from July 2026 to February 2029. Customers should stop using the product immediately if their lot number is included in the recall and can dispose of the drops or return them to the place of purchase.
Original reporting: NBC4 Los Angeles — read the source article.
